Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 401

1.

RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.

Park JS, Choi HI, Kim DH, Kim CS, Bae EH, Ma SK, Kim SW.

Int J Mol Sci. 2019 Nov 4;20(21). pii: E5489. doi: 10.3390/ijms20215489.

2.

Usefulness of the duration of acute kidney injury for predicting renal function recovery after partial nephrectomy.

Kim CS, Bae EH, Ma SK, Kim SW.

Ann Transl Med. 2019 Sep;7(Suppl 6):S236. doi: 10.21037/atm.2019.08.38. No abstract available.

3.

PGC-1α Suppresses the Activation of TGF-β/Smad Signaling via Targeting TGFβRI Downregulation by let-7b/c Upregulation.

Choi HI, Park JS, Kim DH, Kim CS, Bae EH, Ma SK, Kim SW.

Int J Mol Sci. 2019 Oct 14;20(20). pii: E5084. doi: 10.3390/ijms20205084.

4.

[Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer].

Wang YT, Li B, Li XG, Ma SK, Zhang R, Wu LY.

Zhonghua Fu Chan Ke Za Zhi. 2019 Sep 25;54(9):588-594. doi: 10.3760/cma.j.issn.0529-567x.2019.09.003. Chinese.

PMID:
31550774
5.

Central Diabetes Insipidus Associated with Orbital Apex Syndrome.

Yoon JH, Cho SH, Lee SH, Ma SK, Kim SW, Bae EH.

J Nippon Med Sch. 2019;86(4):254-257. doi: 10.1272/jnms.JNMS.2019_86-409.

6.

Obstructive sleep apnea as a risk factor for incident end stage renal disease: a nationwide population-based cohort study from Korea.

Choi HS, Kim HY, Han KD, Jung JH, Kim CS, Bae EH, Ma SK, Kim SW.

Clin Exp Nephrol. 2019 Dec;23(12):1391-1397. doi: 10.1007/s10157-019-01779-6. Epub 2019 Aug 29.

PMID:
31468233
7.

Metabolic Syndrome Resolved within Two Years is Still a Risk Factor for Kidney Cancer.

Oh TR, Han KD, Choi HS, Kim CS, Bae EH, Ma SK, Kim SW.

J Clin Med. 2019 Aug 28;8(9). pii: E1329. doi: 10.3390/jcm8091329.

8.

Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.

Bae EH, Lim SY, Han KD, Oh TR, Choi HS, Kim CS, Ma SK, Kim SW.

Hypertension. 2019 Oct;74(4):880-887. doi: 10.1161/HYPERTENSIONAHA.119.13422. Epub 2019 Aug 19.

9.

Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ.

Suh SH, Choi HS, Kim CS, Kim IJ, Ma SK, Scholey JW, Kim SW, Bae EH.

Int J Mol Sci. 2019 Aug 6;20(15). pii: E3843. doi: 10.3390/ijms20153843.

10.

Vascular Stent Migration to Right Ventricle.

Kim CS, Kim HY, Lee KS, Bae EH, Ma SK, Kim SW.

Korean Circ J. 2019 Aug;49(8):769-770. doi: 10.4070/kcj.2019.0120. Epub 2019 Jul 10. No abstract available.

11.

The risk of end-stage renal disease in systemic lupus erythematosus: A nationwide population-based study in Korea.

Choi HS, Han KD, Jung JH, Kim CS, Bae EH, Ma SK, Kim SW.

Medicine (Baltimore). 2019 Jul;98(28):e16420. doi: 10.1097/MD.0000000000016420.

12.

Src-mediated crosstalk between FXR and YAP protects against renal fibrosis.

Kim DH, Choi HI, Park JS, Kim CS, Bae EH, Ma SK, Kim SW.

FASEB J. 2019 Oct;33(10):11109-11122. doi: 10.1096/fj.201900325R. Epub 2019 Jul 12.

PMID:
31298930
13.

Anti-Apoptotic Effect of G-Protein-Coupled Receptor 40 Activation on Tumor Necrosis Factor-α-Induced Injury of Rat Proximal Tubular Cells.

Kim CS, Joo SY, Kim IJ, Choi HI, Bae EH, Kim SW, Ma SK.

Int J Mol Sci. 2019 Jul 10;20(14). pii: E3386. doi: 10.3390/ijms20143386.

14.

Incidence and risk factors for osteoporotic fractures in patients with systemic lupus erythematosus versus matched controls.

Kim CS, Han KD, Jung JH, Choi HS, Bae EH, Ma SK, Kim SW.

Korean J Intern Med. 2019 Jun 26. doi: 10.3904/kjim.2018.378. [Epub ahead of print]

15.

Peroxiredoxin V (PrdxV) negatively regulates EGFR/Stat3-mediated fibrogenesis via a Cys48-dependent interaction between PrdxV and Stat3.

Choi HI, Kim DH, Park JS, Kim IJ, Kim CS, Bae EH, Ma SK, Lee TH, Kim SW.

Sci Rep. 2019 Jun 19;9(1):8751. doi: 10.1038/s41598-019-45347-0.

16.

Trend of prevalence and incidence of systemic lupus erythematosus in South Korea, 2005 to 2015: a nationwide population-based study.

Bae EH, Lim SY, Han KD, Jung JH, Choi HS, Kim HY, Kim CS, Ma SK, Kim SW.

Korean J Intern Med. 2019 Jun 21. doi: 10.3904/kjim.2018.303. [Epub ahead of print]

17.

Optimal blood pressure target and measurement in patients with chronic kidney disease.

Kim CS, Choi HS, Bae EH, Kim SW, Ma SK.

Korean J Intern Med. 2019 Nov;34(6):1181-1187. doi: 10.3904/kjim.2019.164. Epub 2019 Jun 17. Review.

18.

Partial nephrogenic diabetes insipidus associated with Castleman's disease.

Kim M, Choi HS, Bae EH, Ma SK, Kim SW, Kim CS.

BMC Nephrol. 2019 May 14;20(1):168. doi: 10.1186/s12882-019-1343-9.

19.

Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.

Oh TR, Choi HS, Kim CS, Bae EH, Ma SK, Sung SA, Kim YS, Oh KH, Ahn C, Kim SW.

Sci Rep. 2019 Apr 30;9(1):6681. doi: 10.1038/s41598-019-43241-3.

20.

Systemic lupus erythematosus is a risk factor for atrial fibrillation: a nation-wide, population-based study.

Lim SY, Bae EH, Han KD, Jung JH, Choi HS, Kim CS, Ma SK, Kim SW.

Clin Exp Rheumatol. 2019 Mar 18. [Epub ahead of print]

PMID:
30943134
21.

Micrococcus aloeverae - A Rare Cause of Peritoneal Dialysis-Related Peritonitis Confirmed by 16S rRNA Gene Sequencing.

Song SH, Choi HS, Ma SK, Kim SW, Shin JH, Bae EH.

J Nippon Med Sch. 2019;86(1):55-57. doi: 10.1272/jnms.JNMS.2019_86-10.

22.

Long-term Tolvaptan Treatment of Autosomal Dominant Polycystic Kidney Disease in Korea.

Kim HY, Lee SJ, Kim BK, Kim M, Bae EH, Ma SK, Kim SW.

Electrolyte Blood Press. 2018 Dec;16(2):23-26. doi: 10.5049/EBP.2018.16.2.23. Epub 2018 Dec 31.

23.

Alpha-lipoic acid attenuates p-cresyl sulfate-induced renal tubular injury through suppression of apoptosis and autophagy in human proximal tubular epithelial cells.

Park JS, Choi HI, Kim DH, Kim CS, Bae EH, Ma SK, Kim SW.

Biomed Pharmacother. 2019 Apr;112:108679. doi: 10.1016/j.biopha.2019.108679. Epub 2019 Feb 21.

24.

Editorial.

Ma ES, Collins RA.

Hong Kong Med J. 2019 Feb;25 Suppl 3(1):3. No abstract available.

25.

Risk factors for peptic ulcer disease in patients with end-stage renal disease receiving dialysis.

Kim M, Kim CS, Bae EH, Ma SK, Kim SW.

Kidney Res Clin Pract. 2019 Mar 31;38(1):81-89. doi: 10.23876/j.krcp.18.0060.

26.

Clinical Significance of the Interval Change of Plasma Neutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury and Acute Kidney Injury Superimposed on Chronic Kidney Disease.

Kim HY, Kim CS, Bae EH, Kim SW, Ma SK.

Chonnam Med J. 2019 Jan;55(1):68-69. doi: 10.4068/cmj.2019.55.1.68. Epub 2019 Jan 25. No abstract available.

27.

Bilateral Parapelvic Cyst Misdiagnosed as Hydronephrosis.

Choi HS, Kim CS, Bae EH, Ma SK, Kim SW.

Chonnam Med J. 2019 Jan;55(1):65. doi: 10.4068/cmj.2019.55.1.65. Epub 2019 Jan 25. No abstract available.

28.

Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea.

Bae EH, Lim SY, Han KD, Jung JH, Choi HS, Kim CS, Ma SK, Kim SW.

Lupus. 2019 Mar;28(3):317-323. doi: 10.1177/0961203319826672. Epub 2019 Feb 2.

PMID:
30712493
29.

Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats.

Bae EH, Kim IJ, Song JH, Choi HS, Kim CS, Eom GH, Kim I, Cha H, Cho JM, Ma SK, Kim SW.

Int J Mol Sci. 2019 Jan 25;20(3). pii: E508. doi: 10.3390/ijms20030508.

30.

Editorial.

Ma ES, Collins RA.

Hong Kong Med J. 2019 Feb;25 Suppl 2(1):3. No abstract available.

31.

Prospective observational cohort study on grading the severity of postoperative complications in global surgery research.

International Surgical Outcomes Study (ISOS) group.

Br J Surg. 2019 Jan;106(2):e73-e80. doi: 10.1002/bjs.11025.

PMID:
30620066
32.

Hong Kong domestic health spending: financial years 1989/90 to 2014/15.

Lee PY, Johnston JM, Lee PS, Lee YH, Poon KK, Lam DW, Yeung AY, Ma ES.

Hong Kong Med J. 2018 Oct;24 Suppl 8:2-24. No abstract available.

33.

Tamoxifen ameliorates obstructive nephropathy through Src and the PI3K/Akt/mTOR pathway.

Kim CS, Kim IJ, Choi JS, Bae EH, Ma SK, Kim SW.

Biol Cell. 2019 Jan;111(1):18-27. doi: 10.1111/boc.201800040. Epub 2018 Oct 21.

PMID:
30304547
34.

Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea.

Lim SY, Bae EH, Han KD, Jung JH, Choi HS, Kim HY, Kim CS, Ma SK, Kim SW.

Lupus. 2018 Nov;27(13):2050-2056. doi: 10.1177/0961203318804883. Epub 2018 Oct 3.

PMID:
30282562
35.

The Case | A 33-year-old woman with gross hematuria.

Choi HS, Kim SS, Choi HI, Song JH, Kim CS, Bae EH, Ma SK, Kim SW.

Kidney Int. 2018 Oct;94(4):837-838. doi: 10.1016/j.kint.2018.07.007. No abstract available.

PMID:
30243328
36.

Editorial.

Collins RA, Ma ES.

Hong Kong Med J. 2018 Oct;24 Suppl 6(5):3. No abstract available.

37.

Diabetes Insipidus Presenting with Oligohydramnios and Polyuria During Pregnancy.

Choi HS, Kim YH, Kim CS, Ma SK, Kim SW, Bae EH.

J Nippon Med Sch. 2018;85(3):191-193. doi: 10.1272/jnms.JNMS.2018_85-29.

38.

Editorial.

Collins RA, Ma ES.

Hong Kong Med J. 2018 Aug;24 Suppl 4(4):3. No abstract available.

39.

Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease.

Choi HS, Song JH, Kim IJ, Joo SY, Eom GH, Kim I, Cha H, Cho JM, Ma SK, Kim SW, Bae EH.

Sci Rep. 2018 Aug 1;8(1):11546. doi: 10.1038/s41598-018-30008-5.

40.
41.

Editorial.

Collins RA, Ma ES.

Hong Kong Med J. 2017 Jun;23 Suppl 2(3):3. No abstract available.

42.

Hong Kong domestic health spending: financial years 1989/90 to 2013/14.

Song W, Johnston JM, Kee FC, Lee PS, Lee YH, Chong DS, Poon KK, Lam DW, Yeung AY, Ma ES, Maw CK.

Hong Kong Med J. 2017 Jun;23 Suppl 4(3):2-23. No abstract available.

43.

Editorial.

Collins RA, Ma ES.

Hong Kong Med J. 2018 Feb;24 Suppl 2(1):3. No abstract available.

44.

Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations.

Kwong A, Shin VY, Ma ES, Chan CT, Ford JM, Kurian AW, Tai E.

Hong Kong Med J. 2018 Jun;24 Suppl 3(3):4-6. No abstract available.

45.

Editorial.

Collins RA, Ma ES.

Hong Kong Med J. 2018 Jun;24 Suppl 3(3):3. No abstract available.

46.

A Prospective Observational Study on the Predictive Value of Serum Cystatin C for Successful Weaning from Continuous Renal Replacement Therapy.

Kim CS, Bae EH, Ma SK, Kim SW.

Kidney Blood Press Res. 2018;43(3):872-881. doi: 10.1159/000490335. Epub 2018 May 30.

47.

Tumor necrosis factor α-converting enzyme inhibitor attenuates lipopolysaccharide-induced reactive oxygen species and mitogen-activated protein kinase expression in human renal proximal tubule epithelial cells.

Bae EH, Kim IJ, Choi HS, Kim HY, Kim CS, Ma SK, Kim IS, Kim SW.

Korean J Physiol Pharmacol. 2018 Mar;22(2):135-143. doi: 10.4196/kjpp.2018.22.2.135. Epub 2018 Feb 23.

48.

Hemopexin increases the neurotoxicity of hemoglobin when haptoglobin is absent.

Chen-Roetling J, Ma SK, Cao Y, Shah A, Regan RF.

J Neurochem. 2018 Jun;145(6):464-473. doi: 10.1111/jnc.14328. Epub 2018 Apr 3.

49.

The surgical safety checklist and patient outcomes after surgery: a prospective observational cohort study, systematic review and meta-analysis.

Abbott TEF, Ahmad T, Phull MK, Fowler AJ, Hewson R, Biccard BM, Chew MS, Gillies M, Pearse RM; International Surgical Outcomes Study (ISOS) group.

Br J Anaesth. 2018 Jan;120(1):146-155. doi: 10.1016/j.bja.2017.08.002. Epub 2017 Nov 23.

50.

Acute kidney injury due to povidone-iodine ingestion: A case report.

Kim CS, Kim SS, Bae EH, Ma SK, Kim SW.

Medicine (Baltimore). 2017 Dec;96(48):e8879. doi: 10.1097/MD.0000000000008879.

Supplemental Content

Loading ...
Support Center